anti-pd-l1/tgf-β trap in non-hpv associated hnscc
Published 4 years ago • 189 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:39
nivolumab-based induction chemoio & pd-l1 expression in locoregionally advanced hpv-associated opscc
-
4:49
emerging pd-l1 inhibitors for hnscc
-
3:09
m7824: a promising novel antibody for hpv-associated cancers
-
1:52
safety of bca101, an egfr/tgfβ inhibitor, with pembrolizumab in hnscc
-
4:11
cdkn2a and tp53 mutation in hpv-negative hnscc
-
2:31
low or negative pd-l1 head and neck cancertreatment options for patients - hpv advances
-
0:48
how likely will the hpv virus lead to head and neck cancer? penn state cancer institute
-
1:38
combined analyses of pd-l1 and tils for therapy selection in tnbc
-
5:02
high pd-l1head and neck cancer treatment options for patients - hpv advances
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc
-
1:04
the role of pten loss in anti-pd-1 resistance in nsclc
-
2:20
prognostic factors and surgery in hpv-related oropharyngeal cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
3:15
phase ii study of petosemtamab and pembrolizumab for recurrent/metastatic hnscc
-
2:09
hpv status, artificial intelligence, and io in head and neck cancer
-
1:44
updated results of a phase 1a study of anti-pdl1, mpdl3280a, in urothelial bladder cancer
-
2:54
pioneer: understanding pd-l1 resistances in non-small cell lung cancer
-
0:16
oncology for students:which types of hpv are associated with squamous cell carcinoma of the cervix?r
-
4:42
novel fusion proteins to target pd-l1 in hpv associated cancers